Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
In the last decade, three-dimensional (3D) cell culture technology has gained a lot of interest due to its ability to better recapitulate the in vivo organization and microenvironment of in vitro cultured cancer cells. In particular, 3D tumor models have demonstrated several different characteristics compared with traditional two-dimensional (2D) cultures and have provided an interesting link between the latter and animal experiments. Indeed, 3D cell cultures represent a useful platform for the identification of the biological features of cancer cells as well as for the screening of novel antitumor agents. The present review is aimed at summarizing the most common 3D cell culture methods and applications, with a focus on prostate cancer modeling and drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250 · cited 1×
“mice, present a number of problems, such as higher costs, species differences, limited availability, and feasibility [5,8].”
BackgroundCell and environment interactions in tumor microregions: the multicell spheroid model.
Sutherland, R. M. (1988) · Science · doi:10.1126/science.2451290 · Cited by 1,803 · cited 1×
“Indeed, in 3D models only the outer layer of cells directly interacts with the medium, simulating the in vivo hypoxic conditions where only a small portion of tumor tissue is reached by blood vessels [50].”
BackgroundThree-dimensional cell culture: the missing link in drug discovery
Breslin, S., & O’Driscoll, L. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2012.10.003 · Cited by 1,332 · cited 1×
“Furthermore, ethical issues about the use of animals in cancer research are highly controversial, and animal testing is strongly discouraged if it can be replaced with cell culture-based assays [9,10].”
BackgroundProteasome inhibitors in cancer therapy
Manasanch, E. E., & Orlowski, R. Z. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.206 · Cited by 1,024 · cited 1×
“Proteasome inhibitors are a new group of potential antitumor drugs currently under investigation in early-phase clinical trials [108].”
BackgroundA Simple Hanging Drop Cell Culture Protocol for Generation of 3D Spheroids
Foty, R. (2011) · Journal of Visualized Experiments · doi:10.3791/2720 · Cited by 612 · cited 1×
“However, after initiation of the cell culture, it is not possible to replace the media, and chemicals and pharmacological agents can hardly be added in the middle of the drop, significantly limiting the use of this system in drug discovery [20,21].”
BackgroundTumor-derived spheroids: Relevance to cancer stem cells and clinical applications
Ishiguro, T., Ohata, H., Sato, A., Yamawaki, K., Enomoto, T., & Okamoto, K. (2017) · Cancer Science · doi:10.1111/cas.13155 · Cited by 530
Härmä, V., Virtanen, J., Mäkelä, R., Happonen, A., Mpindi, J.-P., Knuuttila, M., Kohonen, P., Lötjönen, J., Kallioniemi, O., & Nees, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010431 · Cited by 344
Microfluidic system for formation of PC-3 prostate cancer co-culture spheroids
Hsiao, A. Y., Torisawa, Y.-S., Tung, Y.-C., Sud, S., Taichman, R. S., Pienta, K. J., & Takayama, S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.047 · Cited by 323 · cited 2×
“Microfluidic devices Uniform spheroids, control of spheroid size, fast spheroid formation, constant perfusion, uniform distribution of oxygen and nutrients Specialized equipment and expertise, expensive, labor-intensive [23]”
BackgroundTaubenberger, A. V., Bray, L. J., Haller, B., Shaposhnykov, A., Binner, M., Freudenberg, U., Guck, J., & Werner, C. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.03.017 · Cited by 139 · cited 1×
“Similarly, PC3 cells seeded in matrix metalloproteinase-degradable biohybrid poly (ethylene) glycol-heparin hydrogels presenting the peptide motifs GFOGER (collagen I) or IKVAV (laminin-111) show an enhanced proliferation and endothelial cell infiltration compared to non-functionalized controls [77].”
BackgroundControlled 3D culture in Matrigel microbeads to analyze clonal acinar development
Dolega, M. E., Abeille, F., Picollet-D'hahan, N., & Gidrol, X. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.042 · Cited by 91
Cited by
In vitro 3d cultures to model the tumor microenvironment
Fontana, F., Marzagalli, M., Sommariva, M., Gagliano, N., & Limonta, P. (2021) · Cancers · doi:10.3390/cancers13122970 · Cited by 103
“Scaffolds Accurate tissue recapitulation Expensive, variability in polymer composition [14,17,18]”
BackgroundSelf-citationPadmyastuti, A., Sarmiento, M. G., Dib, M., Ehrhardt, J., Schoon, J., Somova, M., Burchardt, M., Roennau, C., & Pinto, P. C. (2023) · Scientific Reports · doi:10.1038/s41598-023-38834-y · Cited by 17
Differentiation States of Phenotypic Transition of Melanoma Cells Are Revealed by 3D Cell Cultures
Fontana, F., Sommariva, M., Anselmi, M., Bianchi, F., Limonta, P., & Gagliano, N. (2024) · Cells · doi:10.3390/cells13020181 · Cited by 11
“…lines and support the importance of studying the characteristics and behavior of melanoma cells in 3D spheroids, which might represent an in vitro pre-clinical model able to identify tumor markers and study new therapeutic tools in melanoma, as previously demonstrated in other tumors [36,38,92,93].”
BackgroundSelf-citation
Metadata
- Authors
- Fontana, F., Raimondi, M., Marzagalli, M., Sommariva, M., Gagliano, N., & Limonta, P.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-09-16
- Volume
- 21
- Issue
- 18
- Pages
- 6806
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3085026763
- Cited by
- 56
- References
- 11
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.